BioSpace News Archive

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that Robin C. Kramer was elected by the Armata shareholders to the Company’s Board of Directors at the Company’s Annual Shareholders Meeting,

Slowing of neuropathy progression for all 7 evaluable patients , evidenced by a +1.29 point mean change in NIS , was more favorable than expected progression of +9.2 points Improvement in neuropathy for 3 of these 7 evaluable patients demonstrated by a mean change in NIS of – 3.33 points I mprovement in cardiac function for all 7 evaluable patients demonstrated by a decrease in global longitudinal strain (GLS) Investor conference call and webcast

Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that CEO Waqaas Al-Siddiq and CFO John Ayanoglou are scheduled to present to a live audience at the 13 th Annual LD Micro Main Event virtual investor conference on December 15th, 2020 at 10:20 am Pacific Time (1:20 pm ET). The online presentation will be webcast live and available for replay at the investor relations section

Delcath Systems, Inc., an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced the pricing of an underwritten public offering of 1,460,027 shares of its common stock at a public offering price of $13.25 per share.

Thermo Fisher Scientific, the world leader in serving science, today announced it will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines.

Mirimus’ SalivaClear monitored all players, coaches, tournament staff and internal media for SARS-CoV-2, with results provided within 24-hours of each pooled test More than 1,900 SalivaClear COVID-19 tests conducted during unprecedented 10-day basketball event

Eric Schadt , Ph.D., the Founder and CEO of Sema4 , a patient-centered health intelligence company, has been named the 2020 BioCT Entrepreneur of the Year. The Entrepreneur of the Year award was established by BioCT and the law firm of Shipman & Goodwin LLP to acknowledge the importance of showcasing unique accomplishments of entrepreneurs in the Connecticut community whose achievements are also having an im

Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy, today announced that President & CEO Usman “Oz” Azam will participate in a Fireside Chat at the 2020 RBC Capital Markets Healthcare Private Company Conference on Tuesday, December 15, 2020 at 11:20 am Eastern Time. To access a liv

Nationwide survey believed to be the first to reveal insights into U.S. consumer behaviors and attitudes toward COVID-19 testing and health effects since fall-winter COVID-19 wave began

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it is the first company to offer clients Good Laboratory Practices (GLP) validated digital peer review using Deciphex Patholytix Preclinical for toxicologic pathology. Through its partnership with Deciphex